Navigation Links
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
Date:1/29/2009

n patients requiring continuous, around-the-clock opioid treatment for an extended period of time; and VOLTAREN(R) gel, a nonsteroidal anti-inflammatory drug indicated for the relief of the pain of osteoarthritis of joints amenable to topical treatment. The company markets its branded pharmaceutical products to physicians in pain management, neurology, surgery, oncology, and primary care. More information, including this and past press releases of Endo Pharmaceuticals, is available at www.endo.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "intend," "guidance" or similar expressions are forward-looking statements. Because these statements reflect our current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors could affect our future financial results and could cause our actual results to differ materially from those expressed in forward-looking statements contained in this press release. Risks and uncertainties include the satisfaction of closing conditions for the acquisition, including clearance under the Hart-Scott-Rodino Antitrust Improvements Act; the tender of a majority of the outstanding shares of common stock of Indevus; the possibility that the transaction will not be completed, or if completed, not completed on a timely basis; the possibility that the acquisition of Indevus is not complementary to Endo; the potential that market segment growth will not follow historical patterns; general industry conditions and competition; business and economic conditions, such as interest rate and currency exchange rate fluc
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Colo. , Nov. 25, 2014 /PRNewswire/ ... ) today announced that its Chief Executive ... at the following upcoming conferences.  The public ... through webcasts on the Array BioPharma website:  ... December 3, 2014Time:1:30 p.m.  Eastern Time Location: ...
(Date:11/26/2014)... Nov. 25, 2014 Immune Pharmaceuticals Inc. ... stage biopharmaceutical company that engages in the development ... of inflammatory diseases and cancer, today announced the ... of 3,450,000 units, with each unit consisting of ... value $0.0001 per share, and one warrant to ...
(Date:11/24/2014)...  CryoLife, Inc. (NYSE: CRY ), a leading ... vascular surgery, announced today that it will participate in the ... Wednesday, December 3, 2014 at The New York Palace Hotel ... A live webcast of the Company,s presentation is scheduled to ... of the company by Pat Mackin , President and ...
Breaking Medicine Technology:Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 2Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 3Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 4Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 5CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 3
(Date:11/26/2014)... Dr. Parsa Mohebi is giving prospective ... With Parsa Mohebi Hair Restoration’s new winter special, patients ... FUE procedure, making it that much easier to get ... Unit Extraction”—is an advanced variety of hair restoration surgery ... Transplantation (FUT). FUE, unlike FUT, does not leave a ...
(Date:11/26/2014)... 27, 2014 Recently, Locks-Magnetic.com, a Chinese ... collection of magnetic locks on the Internet. It also ... until December. , As a leading company in ... for worldwide customers to buy high quality locks. It ... it provides locks that are not only useful but ...
(Date:11/26/2014)... (PRWEB) November 27, 2014 Boxing Day ... and tradesmen would receive gifts, known as a "Christmas ... Wikipedia ) , With the coming of Boxing Day, ... Tbdress.com is smart before every business opportunity, and it ... ”, offering a site-wide promotion for its global customers. ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Pharmaceutical ... humidity, and pressure levels during manufacturing and research ... and air conditioning) systems play a key role. ... microorganisms or bio-contaminants, while humidity can affect the ... The use of HVAC systems helps to address ...
(Date:11/26/2014)... Dallas, Texas (PRWEB) November 26, 2014 ... surgeon and Distinguished Teaching Professor in the ... Center, recently discussed facial fat compartments, fat grafting, ... Surgery, The Meeting," an annual conference held by ... importance and intricacies of this underlying facial structure ...
Breaking Medicine News(10 mins):Health News:FUE Special at Parsa Mohebi Hair Restoration This Holiday Season 2Health News:Fresh Products Launched by Famous Company Lock-Magnetic.com 2Health News:Tbdress.com: Best Boxing Day Sales For Ladies Worldwide 2Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 5Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 2Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 3
... Socit de Pathologie Exotique , launched shortly after the ... and English as well as meeting reports. Today, ... and is recognized for its impressive collection of tropical ... students, the Bulletin appears five times per year and ...
... suggests that exempting bars from community smoking bans makes ... and that even the most comprehensive clean indoor air ... jobs. , Researchers hope the findings, based on a ... municipalities and states considering the economic and health issues ...
... Equality,s Judicial Victory Leads to Legislative ... Guardianship CHICAGO, May 18 Today, the Illinois ... adults with disabilities under guardianship without due process. ... disabilities under guardianship has been preserved. The bill, ...
... into State-of-the-Art Neonatal Intensive Care Unit WASHINGTON, May ... home at Children,s National Medical Center. The new, ... when the babies were transported from the hospital,s ... http://www.newscom.com/cgi-bin/prnh/20090518/DC18562 )"This NICU was ...
... Now Available for Use in Clinical Trials and Population Health ... vital to health and well-being as a good night,s sleep. ... the National Sleep Foundation -- suffer from chronic sleep problems ... showing correlations between poor or insufficient sleep and disease. Now ...
... resource from ACTS Retirement-Life Communities helps consumers ask the right questions ... ... West Point, PA (Vocus) May 18, 2009 -- Preparing ... many factors to consider, including present and future needs, personal preferences, ...
Cached Medicine News:Health News:Study: Smoking bans do not cause job losses in bars and restaurants 2Health News:Study: Smoking bans do not cause job losses in bars and restaurants 3Health News:Study: Smoking bans do not cause job losses in bars and restaurants 4Health News:Passage of Illinois House Bill 2290 Adds Crucial Due Process Protection Governing Sterilization of Adults With Disabilities 2Health News:Passage of Illinois House Bill 2290 Adds Crucial Due Process Protection Governing Sterilization of Adults With Disabilities 3Health News:The Most Fragile Babies in the Nation's Capital Have a New Home 2Health News:QualityMetric Offers Way to Measure the Impact of Sleep Problems on Individuals and Groups 2Health News:7 Tips for Choosing a Retirement Community 2Health News:7 Tips for Choosing a Retirement Community 3
This 10 L tip was designed for the Pipetman P-2 and P-10. Its MicroPoint design and 2 L reference mark make it ideal for low volume pipetting....
1000 L, Bulk Recommended for 500 and 1000 L pipettes....
... been designed to optimize the accuracy and ... tip products is widely recognized by customers ... been extended over the years and now ... special tips including filter tips, certified pure ...
Inquire...
Medicine Products: